Literature DB >> 23615688

Is it time to reevaluate definitive therapy in prostate cancer?

Ravi A Madan, Avni A Shah, William L Dahut.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23615688      PMCID： PMC3691939          DOI： 10.1093/jnci/djt094

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  22 in total

1.  Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

Authors:  Miljenko V Pilepich; Kathryn Winter; Colleen A Lawton; Robert E Krisch; Harvey B Wolkov; Benjamin Movsas; Eugen B Hug; Sucha O Asbell; David Grignon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-04-01       Impact factor: 7.038

2.  Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

Authors:  Stephanie T H Peeters; Wilma D Heemsbergen; Peter C M Koper; Wim L J van Putten; Annerie Slot; Michel F H Dielwart; Johannes M G Bonfrer; Luca Incrocci; Joos V Lebesque
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

3.  Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.

Authors:  E M Messing; J Manola; M Sarosdy; G Wilding; E D Crawford; D Trump
Journal:  N Engl J Med       Date:  1999-12-09       Impact factor: 91.245

4.  Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities.

Authors:  K Akakura; S Isaka; S Akimoto; H Ito; K Okada; T Hachiya; O Yoshida; Y Arai; M Usami; T Kotake; K Tobisu; Y Ohashi; Y Sumiyoshi; T Kakizoe; J Shimazaki
Journal:  Urology       Date:  1999-08       Impact factor: 2.649

5.  Randomized series of treatment with surgery versus radiation for prostate adenocarcinoma.

Authors:  D F Paulson
Journal:  NCI Monogr       Date:  1988

6.  Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach.

Authors:  Ashutosh Tewari; George Divine; Peter Chang; M Mendel Shemtov; Matthew Milowsky; David Nanus; Mani Menon
Journal:  J Urol       Date:  2007-03       Impact factor: 7.450

7.  13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.

Authors:  Peter C Albertsen; James A Hanley; David F Penson; George Barrows; Judith Fine
Journal:  J Urol       Date:  2007-03       Impact factor: 7.450

8.  Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial.

Authors:  Alan Pollack; Gunar K Zagars; George Starkschall; John A Antolak; J Jack Lee; Eugene Huang; Andrew C von Eschenbach; Deborah A Kuban; Isaac Rosen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

9.  Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer.

Authors:  Richard M Hoffman; Tatsuki Koyama; Kang-Hsien Fan; Peter C Albertsen; Michael J Barry; Michael Goodman; Ann S Hamilton; Arnold L Potosky; Janet L Stanford; Antoinette M Stroup; David F Penson
Journal:  J Natl Cancer Inst       Date:  2013-04-24       Impact factor: 13.506

10.  Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

Authors:  Anthony V D'Amico; Judd Moul; Peter R Carroll; Leon Sun; Deborah Lubeck; Ming-Hui Chen
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544
View more
  2 in total

1.  Piloting prostate cancer patient-reported outcomesin clinical practice.

Authors:  Martin Korzeniowski; Maria Kalyvas; Aamer Mahmud; Carey Shenfield; Christine Tong; Khaled Zaza; Doris Howell; Michael Brundage
Journal:  Support Care Cancer       Date:  2015-10-24       Impact factor: 3.359

2.  Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer.

Authors:  Shashwat Sharad; Lakshmi Ravindranath; Michael C Haffner; Hua Li; Wusheng Yan; Isabell A Sesterhenn; Yongmei Chen; Amina Ali; Alagarsamy Srinivasan; David G McLeod; Srinivasan Yegnasubramanian; Shiv Srivastava; Albert Dobi; Gyorgy Petrovics
Journal:  Epigenetics       Date:  2014-04-02       Impact factor: 4.528
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.